According to previous studies, the N-terminal portion of TCF7 contains the β-catenin-binding domain that is important for Wnt signaling-determined tumorigenicity, which suggests that TCF7 may act as a Wnt effector in carcinomas (29, 30). Here, TCF7 is linked to carcinoma.